Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

BACKGROUND: Adjuvant therapy with an aromatase inhibitor improves outcomes, as compared with tamoxifen, in postmenopausal women with hormone-receptor–positive breast cancer. METHODS: In two phase 3 trials, we randomly assigned premenopausal women with hormone-receptor–positive early breast cancer to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pagani, Olivia, Regan, Meredith M., Walley, Barbara A., Fleming, Gini F., Colleoni, Marco, Láng, István, Gomez, Henry L., Tondini, Carlo, Burstein, Harold J., Perez, Edith A., Ciruelos, Eva, Stearns, Vered, Bonnefoi, Hervé R., Martino, Silvana, Geyer, Charles E., Pinotti, Graziella, Puglisi, Fabio, Crivellari, Diana, Ruhstaller, Thomas, Winer, Eric P., Rabaglio-Poretti, Manuela, Maibach, Rudolf, Ruepp, Barbara, Giobbie-Hurder, Anita, Price, Karen N., Bernhard, Jürg, Luo, Weixiu, Ribi, Karin, Viale, Giuseppe, Coates, Alan S., Gelber, Richard D., Goldhirsch, Aron, Francis, Prudence A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4175521/
https://ncbi.nlm.nih.gov/pubmed/24881463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1404037
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados